Current Concepts on the Use of Glucocorticosteroids and Beta-2-Adrenoreceptor Agonists to Treat Childhood Asthma

Current Opinion in Pediatrics - United States
doi 10.1097/mop.0b013e328337cb0c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Long Acting Beta-2 Agonists in the Treatment of Asthma and Their Safety

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2011English

Glucocorticosteroids: Current and Future Directions

British Journal of Pharmacology
Pharmacology
2011English

Childhood Hypophosphatasia: To Treat or Not to Treat

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2018English

Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroids for Chronic Asthma in Children

2009English

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2015English

Prs1 Severe Asthma Exacerbations Associated With Long-Acting Beta Agonists Among Children and Adolescents With Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Long-Acting 2-Agonists in Asthma: Safety Concerns

CMAJ
Medicine
2005English

How to Diagnose and Treat Acute Asthma

Canadian Journal of Emergency Medicine
Emergency Medicine
2019English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy